BDXB — Becton Dickinson and Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual income statement for Becton Dickinson and Co, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	C2018 September 30th	2019 September 30th	R2020 September 30th	R2021 September 30th	2022 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	15,983	17,290	16,074	19,131	18,870
Cost of Revenue
Gross Profit	7,269	8,288	7,140	8,687	8,603
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,490	15,554	15,170	17,059	16,579
Operating Profit	1,493	1,736	904	2,072	2,291
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,173	1,176	414	1,692	1,783
Provision for Income Taxes
Net Income After Taxes	951	1,183	352	1,604	1,635
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	311	1,233	874	2,092	1,779
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	159	1,082	767	2,002	1,689
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.99	6.55	6.23	8.6	8.79
Dividends per Share